Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI) Stock Price, Quote & AI Analysis
Live RANI stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Rani Therapeutics Holdings, Inc. Class A Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Rani Therapeutics Holdings, Inc. Class A Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Rani Therapeutics Holdings, Inc. Class A Common Stock Overview
Company information
Company Overview
Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Rani Therapeutics Holdings, Inc. Class A Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...